Frost & Sullivan releases the 'Market Research Report on Pharmaceutical R&D Outsourcing Services'

The global pharmaceutical market size reached $1.495 trillion in 2022 and is expected to increase to $2.0908 trillion by 2030. In addition to leading market sizes, the pharmaceutical markets in the United States and China show higher growth rates compared to other regions of the world. The main driving factors include: growing pharmaceutical demand, the continuous approval and launch of innovative drugs, and the rapid development of the CRO market. The development of the CRO market has accelerated the R&D progress of pharmaceutical companies. The rapid development of the pharmaceutical market has increased the demand for CRO services by pharmaceutical companies, which can help pharmaceutical companies reduce costs, control risks, improve R&D efficiency, and enhance their competitiveness. Based on a long-term tracking of the pharmaceutical R&D outsourcing service market, Frost & Sullivan hereby releases the 'Industry Research Report on the Pharmaceutical R&D Outsourcing Service Market'.